AmideBio, LLC
Biotechnology company · Boulder, Colorado, United States
AmideBio, LLC is a biotechnology company headquartered in Boulder, Colorado, United States. Its earliest recorded incorporation is in 2009. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $6.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $763,517 sold in a notice filed in 2017.
AmideBio at a glance
What does AmideBio do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $6.8 million in total (2017 to 2024). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $763,517 sold (2017).
Frequently asked questions about AmideBio
Where is AmideBio headquartered?
AmideBio, LLC is headquartered in Boulder, Colorado, United States.
What does AmideBio do?
AmideBio, LLC is a biotechnology company.
When was AmideBio founded?
The earliest incorporation on record for AmideBio, LLC is in 2009, according to public company registers.
Similar companies
- MBio Diagnostics, Inc.Boulder, Colorado, United States
- InDevR, Inc.Boulder, Colorado, United States
- Fresh Tracks Therapeutics, Inc.Boulder, Colorado, United States
- Lazzaro Medical, Inc.Boulder, Colorado, United States
- EndoShape, Inc.Boulder, Colorado, United States
- Orbit Genomics, Inc.Boulder, Colorado, United States
- Crestone, Inc.Boulder, Colorado, United States
- Enveda Therapeutics, Inc.Boulder, Colorado, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences